226 related articles for article (PubMed ID: 6172388)
21. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
Ruco LP; Meltzer MS
J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-12-mediated tumoricidal activity of patient lymphocytes in an autologous in vitro ovarian cancer assay system.
DeCesare SL; Michelini-Norris B; Blanchard DK; Barton DP; Cavanagh D; Roberts WS; Fiorica JV; Hoffman MS; Djeu JY
Gynecol Oncol; 1995 Apr; 57(1):86-95. PubMed ID: 7705706
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
25. A macrophage activating factor is present and active in the ascitic fluid of patients with ovarian cancer.
Kaneko M; Nishida M; Iwasaki H
J Cancer Res Clin Oncol; 1985; 110(2):131-5. PubMed ID: 3900084
[TBL] [Abstract][Full Text] [Related]
26. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma.
Sica A; Saccani A; Bottazzi B; Bernasconi S; Allavena P; Gaetano B; Fei F; LaRosa G; Scotton C; Balkwill F; Mantovani A
J Immunol; 2000 Jan; 164(2):733-8. PubMed ID: 10623817
[TBL] [Abstract][Full Text] [Related]
27. Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma.
Melichar B; Savary CA; Patenia R; Templin S; Melicharova K; Freedman RS
Int J Gynecol Cancer; 2003; 13(4):435-43. PubMed ID: 12911719
[TBL] [Abstract][Full Text] [Related]
28. Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions.
Fidler IJ; Kleinerman ES
J Clin Oncol; 1984 Aug; 2(8):937-43. PubMed ID: 6379124
[TBL] [Abstract][Full Text] [Related]
29. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
[TBL] [Abstract][Full Text] [Related]
30. Macrophages as cytotoxic effector cells.
Lohmann-Matthes ML; Lang H; Sun D
Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species.
Weinberg JB; Haney AF
J Natl Cancer Inst; 1983 Jun; 70(6):1005-10. PubMed ID: 6574267
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
Fischer DG; Golightly MG; Koren HS
J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
[TBL] [Abstract][Full Text] [Related]
33. Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors.
Mantovani A; Peri G; Polentarutti N; Bolis G; Mangioni C; Spreafico F
Int J Cancer; 1979 Feb; 23(2):157-64. PubMed ID: 761940
[TBL] [Abstract][Full Text] [Related]
34. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1.
Ralph P; Nakoinz I
Cell Immunol; 1987 Apr; 105(2):270-9. PubMed ID: 2436807
[TBL] [Abstract][Full Text] [Related]
36. In vitro influence of endotoxin on human mononuclear phagocyte structure and function. 2. Enhancement of the expression of cytoststic and cytolytic activity of normal and lymphokine-activated monocytes.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):391-9. PubMed ID: 397718
[TBL] [Abstract][Full Text] [Related]
37. Macrophage activation for tumor cytotoxicity: regulatory mechanisms for induction and control of cytotoxic activity.
Meltzer MS; Occhionero M; Ruco LP
Fed Proc; 1982 Apr; 41(6):2198-205. PubMed ID: 7075791
[TBL] [Abstract][Full Text] [Related]
38. Endotoxin suppresses the generation of O2- and H2O2 by "resting" and lymphokine-activated human blood-derived macrophages.
Rellstab P; Schaffner A
J Immunol; 1989 Apr; 142(8):2813-20. PubMed ID: 2539412
[TBL] [Abstract][Full Text] [Related]
39. Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin.
Chang ZL; Bonvini E; Varesio L; Holden HT; Herberman RB
Cell Immunol; 1988 Jul; 114(2):282-92. PubMed ID: 2839302
[TBL] [Abstract][Full Text] [Related]
40. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages.
Bernasconi S; Matteucci C; Sironi M; Conni M; Colotta F; Mosca M; Colombo N; Bonazzi C; Landoni F; Corbetta G
Int J Cancer; 1995 Jan; 60(3):300-7. PubMed ID: 7829234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
